Evidence map›Paper›PMID 34754829›Full record

ReviewWorld journal of orthopedics2021

Bicruciate-retaining total knee arthroplasty: What's new?

Luigi Sabatini, Luca Barberis, Daniele Camazzola, Michele Centola, Marcello Capella, Alessandro Bistolfi, Marco Schiraldi, Alessandro Massè

Abstract readReview
In one paragraph

Review in World journal of orthopedics, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Luigi SabatiniOrthopaedics and Traumatology Department, Presidio CTO, Torino 10126, Italy. luigisabatini.ort@gmail.com.
Luca BarberisOrthopaedics and Traumatology Department, Presidio CTO, Torino 10126, Italy.
Daniele CamazzolaOrthopaedics and Traumatology Department, CTO Hospital, Torino 10126, Italy.
Michele CentolaOrthopaedics and Traumatology Department, Presidio CTO, Torino 10126, Italy.
Marcello CapellaOrthopaedics and Traumatology Department, CTO Hospital, Torino 10126, Italy.
Alessandro BistolfiOrthopaedics and Traumatology Department, Presidio CTO, Torino 10126, Italy.
Marco SchiraldiOrthopedics and Traumaology Department, Michele e Pietro Ferrero Hospital, Verduno 12060, Italy.
Alessandro MassèOrthopaedics and Traumatology Department, CTO Hospital, Torino 10126, Italy.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Primary total knee arthroplasty (TKA) is a widespread procedure to address end stage osteoarthritis with good results, clinical outcomes, and long-term survivorship. Although it is frequently performed in elderly, an increased demand in young and active people is expected in the next years. However, a considerable dissatisfaction rate has been reported by highly demanding patients due to the intrinsic limitations provided by the TKA. Bicruciate-retaining (BCR) TKA was developed to mimic knee biomechanics, through anterior cruciate ligament preservation. First-generation BCR TKA has not gained popularity due to its being a challenging technique and having poor survival outcomes. Thanks to implant design improvement and surgeon-friendly instrumentation, second-generation BCR TKA has seen renewed interest. This review will focus on surgical indications, kinematical basis, clinical results and latest developments of second-generation BCR TKA.

Indexed as

Anterior cruciate ligamentBicruciate retainingKnee kinematicsKnee osteoarthritis treatmentSecond generation designTotal knee arthroplasty

Identifiers

PMID34754829
PMCPMC8554348

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.